In a bid to associate themselves with the vanguard of professional practice, marketers are ever-eager to embrace new technologies, though in highly regulated sectors, the shock of the new has a little extra resonance. Intuitively, healthcare advertisers are among the most conservative, as the downside risk of getting marketing wrong is materially higher than for their counterparts in other verticals, such as CPG, given regulatory oversight from bodies such as the Food and Drug Administration and the Federal Trade Commission, and a host of privacy regulators. Given the risks to patient safety, subsequent litigation risk, government oversight…
This is a curated summary. The full story was reported by Digiday.
Read the full story at Digiday
